Classes
Publications
- Dual antiagregant therapy, indication and risk in elderly patient2012 | First Faculty of Medicine
- Metabolic syndrome - new approaches2011 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipoproteinaemia 1. Classification, diagnostics, cardiovascular, cardiometabolic, residual risk2010 | First Faculty of Medicine
- Metabolism +12010 | First Faculty of Medicine
- Lower wall shear rate of the common carotid artery in treated type 2 diabetes mellitus with metabolic syndrome2009 | First Faculty of Medicine
- Lipid-lowering treatment in metabolic syndrome2009 | First Faculty of Medicine
- Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Jistoty a nejistoty na křižovatkách současné medicíny2023 | First Faculty of Medicine
- Slibný perorální inhibitor PCSK9 ve vývoji2023 | First Faculty of Medicine
- Internista2023 | First Faculty of Medicine
Loading network view...